Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
19 studies found for:    Northwestern AND Scleroderma
Show Display Options
Rank Status Study
1 Recruiting Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
Condition: Scleroderma
Interventions: Procedure: Cytoxan rATG/Fludarabine/HSCT;   Procedure: Cytoxan rATG/HSCT
2 Completed
Has Results
Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma
Condition: SYSTEMIC SCLERODERMA
Interventions: Drug: standard of care;   Procedure: stem cell transplantation
3 Completed Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
Condition: Systemic Sclerosis
Intervention:
4 Terminated Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Condition: Scleroderma
Intervention: Biological: Hematopoietic stem cell transplantation
5 Recruiting Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
Conditions: Interstitial Lung Disease;   ILD;   Systemic Sclerosis;   Scleroderma
Interventions: Drug: Bortezomib;   Drug: Placebo;   Drug: Mycophenolate mofetil
6 Terminated Molecular Effects of Topical Calcipotriene on Morphea
Conditions: Morphea;   Localized Scleroderma
Intervention: Drug: topical calcipotriene 0.005% ointment
7 Active, not recruiting Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)
Conditions: Scleroderma;   Systemic Sclerosis;   Raynaud Phenomena;   Raynaud's Disease
Interventions: Device: Celution Device;   Other: Placebo
8 Active, not recruiting A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
Condition: Diffuse Cutaneous Systemic Sclerosis
Interventions: Drug: Abatacept;   Drug: Placebo
9 Terminated
Has Results
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Condition: Digital Ulcers
Interventions: Drug: Macitentan 3 mg;   Drug: Macitentan 10 mg;   Drug: Placebo
10 Recruiting A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Condition: Scleroderma, Systemic
Interventions: Drug: Nintedanib;   Drug: Placebo
11 Completed
Has Results
Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
Conditions: Systemic Sclerosis;   Scleroderma
Interventions: Drug: treprostinil diethanolamine;   Drug: placebo
12 Completed
Has Results
Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
Condition: Scleroderma
Intervention: Drug: dasatinib
13 Completed
Has Results
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Condition: Systemic Sclerosis
Intervention: Drug: Pirfenidone
14 Completed Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Conditions: Systemic Sclerosis;   Scleroderma;   Pulmonary Hypertension;   Pulmonary Arterial Hypertension
Intervention:
15 Completed
Has Results
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Conditions: Scleroderma;   Interstitial Lung Disease
Interventions: Drug: Mycophenolate mofetil;   Drug: Cyclophosphamide;   Drug: Placebo
16 Terminated
Has Results
Open-Label Study of Oral Treprostinil in Digital Ulcers
Condition: Systemic Sclerosis
Intervention: Drug: treprostinil diethanolamine
17 Completed Oral Type I Collagen for Relieving Scleroderma
Conditions: Scleroderma;   Connective Tissue Diseases
Interventions: Drug: Oral bovine type I collagen;   Drug: Placebo
18 Terminated Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)
Conditions: Systemic Sclerosis;   Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Intervention:
19 Completed Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome;   Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid;   Scleroderma, Systemic
Intervention: Drug: Ophthalmic Emulsion

Study has passed its completion date and status has not been verified in more than two years.